Inventor
KOSKIMIES PASI
FI15 patents
⚠️ This page may combine multiple inventors who share the name “KOSKIMIES PASI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORENDO PHARMA LTD
7 patentsUS11254703B2Feb 22, 2022
Therapeutically active steroidal derivatives
FORENDO PHARMA LTD1 citations54
US10717761B2Jul 21, 2020
Therapeutically active steroidal derivatives
FORENDO PHARMA LTD1 citations54
US10626140B2Apr 21, 2020
Prodrugs of 17β-HSD1-inhibitors
FORENDO PHARMA LTD0 citations47
US10377791B2Aug 13, 2019
Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1
FORENDO PHARMA LTD0 citations38
US9850272B2Dec 26, 2017
Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1
FORENDO PHARMA LTD0 citations38
US9663549B2May 30, 2017
Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase
FORENDO PHARMA LTD0 citations38
US10413557B2Sep 17, 2019
Prodrugs of 17.BETA.-HSD1-inhibitors
FORENDO PHARMA LTD0 citations36
MESSINGER JOSEF
4 patentsUS8288367B2Oct 16, 2012
Substituted estratriene derivatives as 17BETA HSD inhibitors
MESSINGER JOSEF2 citations57
US8435973B2May 7, 2013
17-beta HSD1 and STS inhibitors
MESSINGER JOSEF0 citations46
US8080540B2Dec 20, 2011
Therapeutically active triazoles and their use
MESSINGER JOSEF0 citations33
US8088758B2Jan 3, 2012
17β-hydroxysteroid dehydrogenase type I inhibitors
MESSINGER JOSEF0 citations30
SOLVAY PHARM BV
3 patentsUS7524853B2Apr 28, 2009
Compounds and their use in therapy
SOLVAY PHARM BV1 citations40
US7754709B2Jul 13, 2010
Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
SOLVAY PHARM BV1 citations37
US7465739B2Dec 16, 2008
Compounds and their use in therapy
SOLVAY PHARM BV0 citations30